Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database

References

• Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020; Jun 27395(10242):2008–2020. doi:10.1016/S0140-6736(20)30974-0.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; Nov68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; Jun 174(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155.
   PubMed Web of Science ®Google Scholar
• Mohammed S, Van Buren G, 2nd, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014; Jul 2820(28):9354–9360.
   PubMed Web of Science ®Google Scholar
• Lowy AM. Neoadjuvant therapy for pancreatic cancer. J Gastrointest Surg. 2008; Sep12(9):1600–1608. doi:10.1007/s11605-008-0482-2.
   PubMed Web of Science ®Google Scholar
• Ma SJ, Oladeru OT, Miccio JA, et al. Association of timing of adjuvant therapy with survival in patients with resected stage I to II pancreatic cancer. JAMA Netw Open. 2019; Aug 22(8):e199126. doi:10.1001/jamanetworkopen.2019.9126.
   PubMed Web of Science ®Google Scholar
• Fesinmeyer MD, Austin MA, Li CI, et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005; Jul14(7):1766–1773. doi:10.1158/1055-9965.EPI-05-0120.
   PubMed Web of Science ®Google Scholar
• Hopwood D. Histological typing of tumours of the exocrine pancreas. J Clin Pathol. 1996;49(9):780–780. doi:10.1136/jcp.49.9.780-b.
   PubMedGoogle Scholar
• Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg. 2018; Jun 1153(6):588–589. doi:10.1001/jamasurg.2018.0501.
   PubMed Web of Science ®Google Scholar
• Badiyan SN, Molitoris JK, Chuong MD, et al. The role of radiation therapy for pancreatic cancer in the adjuvant and neoadjuvant settings. Surg Oncol Clin N Am. 2017; Jul26(3):431–453. doi:10.1016/j.soc.2017.01.012.
   PubMed Web of Science ®Google Scholar
• Nipp R, Tramontano AC, Kong CY, et al. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018; Feb7(2):525–535. doi:10.1002/cam4.1277.
   PubMed Web of Science ®Google Scholar
• Reyngold M, Winter KA, Regine WF, et al. Marital status and overall survival in patients with resectable pancreatic cancer: results of an ancillary analysis of NRG oncology/RTOG 9704. Oncologist. 2020; Mar25(3):e477–e83. doi:10.1634/theoncologist.2019-0562.
   PubMed Web of Science ®Google Scholar
• Sun K, Li W, Han J, et al. Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma. BMC Cancer. 2019; Aug 119(1):761. doi:10.1186/s12885-019-5966-9.
   PubMed Web of Science ®Google Scholar
• Adamska A, Domenichini A, Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci. 2017; Jun 2218(7):1338. doi: 10.3390/ijms18071338.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; Jan70(1):7–30. doi:10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001; Nov 10358(9293):1576–1585. doi:10.1016/s0140-6736(01)06651-x.
   PubMed Web of Science ®Google Scholar
• Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018; Dec 20379(25):2395–2406. doi:10.1056/NEJMoa1809775.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Abel U, Debus J, et al. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol. 2012; Nov 2030(33):4077–4083. doi:10.1200/JCO.2011.38.2960.
   PubMed Web of Science ®Google Scholar
• Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017; Jan 2469(3):345–357. doi:10.1016/j.jacc.2016.10.060.
   PubMed Web of Science ®Google Scholar
• Penning de Vries BBL, Groenwold RHH. Cautionary note: propensity score matching does not account for bias due to censoring. Nephrol Dial Transplant. 2018; Jun 133(6):914–916. doi:10.1093/ndt/gfx198.
   PubMed Web of Science ®Google Scholar
• Fang Y, Pu N, Zhang L, et al. Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database. Ann Transl Med. 2019; Oct7(20):522. doi:10.21037/atm.2019.10.12.
   PubMed Web of Science ®Google Scholar
• Senapati S, Gnanapragassam VS, Moniaux N, et al. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 2012; Jul 1231(28):3346–3356. doi:10.1038/onc.2011.505.
   PubMed Web of Science ®Google Scholar
• Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010; May 2029(20):2893–2904. doi:10.1038/onc.2010.87.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu G, Chen M, et al. Stage IA patients with pancreatic ductal adenocarcinoma cannot benefit from chemotherapy: a propensity score matching study. Front Oncol. 2020;10:1018. doi:10.3389/fonc.2020.01018.
   PubMed Web of Science ®Google Scholar
• Zhai H, Li D, Feng Q, et al. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:a retrospective cohort study in the SEER database. Int J Surg. 2019; Jun66:103–109. doi:10.1016/j.ijsu.2019.03.006.
   PubMed Web of Science ®Google Scholar